Latest filing published 06 Aug 2021 for Selectis Health, INC., €42k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Clifford L. Neuman Esq. (board member) discloses dealings in 3 companies, chiefly Athena Gold Corp, Global Healthcare REIT, Inc. and Biomedical Technology Solutions Holdings Inc. We count 48 filings; the first trade dates from 2 September 2008 and the latest from 9 July 2021.
The open-market side counts 2 purchases for €84k alongside 22 sales for €61k. Taken together, the purchases exceed the sales by €24k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 9 share grants and 2 option exercises. Since January 2021: 2 purchases and no sales on the market.
On 6 August 2021 came the latest disclosure, an open-market purchase for €42k in Global Healthcare REIT, Inc. The median gap between a trade and its publication by SEC (Form 4) is 7 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations